|
C6ORF211 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.039400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.049000E-01 |
| Normal-vs-Stage2 |
3.517600E-01 |
| Normal-vs-Stage3 |
3.537700E-02 |
| Normal-vs-Stage4 |
1.663610E-03 |
| Stage1-vs-Stage2 |
4.064000E-01 |
| Stage1-vs-Stage3 |
3.194400E-02 |
| Stage1-vs-Stage4 |
7.978800E-04 |
| Stage2-vs-Stage3 |
3.625200E-01 |
| Stage2-vs-Stage4 |
4.393500E-02 |
| Stage3-vs-Stage4 |
2.568800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.740810E-01 |
| Normal-vs-AfricanAmerican |
4.686000E-01 |
| Normal-vs-Asian |
4.904100E-02 |
| Caucasian-vs-AfricanAmerican |
9.745000E-01 |
| Caucasian-vs-Asian |
2.749800E-01 |
| AfricanAmerican-vs-Asian |
5.356400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.800000E-01 |
| Normal-vs-Female |
1.700760E-01 |
| Male-vs-Female |
5.833800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.534800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.690500E-02 |
| Normal-vs-Age(61-80Yrs) |
9.156300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.552000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.070800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.746400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.670400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.517400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.194200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.689000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.467890E-02 |
| Classical-VS-Follicular |
8.020000E-02 |
| Classical-VS-Other |
7.568200E-01 |
| Classical-VS-Normal |
2.598600E-01 |
| Tall-VS-Follicular |
1.604520E-03 |
| Tall-VS-Other |
6.029000E-01 |
| Tall-VS-Normal |
5.622600E-03 |
| Follicular-VS-Other |
4.367600E-01 |
| Follicular-VS-Normal |
5.927800E-01 |
| Other-VS-Normal |
4.108800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.705600E-01 |
| Normal-vs-N1 |
2.418200E-03 |
| N0-vs-N1 |
2.561100E-03 |
|
|
